PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
22.62%
Net income growth at 50-75% of ORCL's 38.39%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-4.47%
Negative yoy D&A while ORCL is 1.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
20.95%
Some yoy growth while ORCL is negative at -306.67%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
4.73%
SBC growth while ORCL is negative at -4.62%. John Neff would see competitor possibly controlling share issuance more tightly.
-204.59%
Both reduce yoy usage, with ORCL at -208.15%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-189.00%
Both yoy AR lines negative, with ORCL at -1202.88%. Martin Whitman would suspect an overall sector lean approach or softer demand.
181.20%
Inventory growth well above ORCL's 27.27%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
154.00%
AP growth well above ORCL's 130.96%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-117.28%
Negative yoy usage while ORCL is 3405.79%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
31.33%
Growth of 31.33% while ORCL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
-48.91%
Both yoy CFO lines are negative, with ORCL at -75.27%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
12.94%
Some CapEx rise while ORCL is negative at -2.54%. John Neff would see competitor possibly building capacity while we hold back expansions.
90.51%
Acquisition spending well above ORCL's 103.13%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
20.51%
Some yoy expansion while ORCL is negative at -19.63%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
61.57%
Proceeds from sales/maturities above 1.5x ORCL's 38.11%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-38.51%
We reduce yoy other investing while ORCL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
68.33%
Investing outflow well above ORCL's 29.06%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-22.85%
We cut debt repayment yoy while ORCL is 99.44%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
272.88%
Stock issuance far above ORCL's 234.32%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-14.84%
Both yoy lines negative, with ORCL at -2.41%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.